What We're Reading: Page 201
Industry reads hand-picked by our editors
Apr 23, 2020
-
The Wall Street Journal
Health Chief’s Early Missteps Set Back Coronavirus Response
-
STAT
It started with a rumor. Now data show a drug is effective against graft-versus-host disease
-
Reuters
Blood-pressure drugs are in the crosshairs of COVID-19 research
-
Bloomberg
Harvard's Timothy Springer a Billionaire on Early Moderna Wager
Apr 22, 2020
Apr 21, 2020
-
C&EN
Scaling up remdesivir amid the coronavirus crisis
-
South China Morning Post
China cancels coronavirus clinical trials due to shortage of patients
-
Associated Press
New Zealand could pull off bold goal of eliminating virus
Apr 20, 2020
Apr 17, 2020
-
STAT
Early peek at data on Gilead coronavirus drug suggests coronavirus patients are responding to treatment
-
LifeSciVC
Value Creation And Destruction: Dispersion of Performance In Biotech IPOs
-
Axios
Coronavirus testing is plateauing, while state testing varies widely
-
CNBC
If Sanofi's coronavirus vaccine works, CEO says it can produce up to 600 million doses next year
Apr 16, 2020
-
The Washington Post
Chaotic search for coronavirus treatments undermines efforts, experts say
-
Bloomberg
Gilead Is Said to Hold Arcus Stake Talks, Spurring 54% Rally
-
In the Pipeline
Coronavirus Vaccine Prospects
-
STAT
Scientists tap CRISPR to create a rapid Covid-19 test
Apr 15, 2020
-
The Atlantic
Our Pandemic Summer
-
The Wall Street Journal
U.S. to Cut Funding to World Health Organization Over Coronavirus Response
-
OneZero
New Testing Tech Could Stop the Next Pandemic
-
POLITICO
FEMA ships out nearly 20 million hydroxychloroquine tablets
Previous
